National Institute of Immunology and Vaccine and Infectious Disease Research Center, THSTI, New Delhi 110067, India.
J Virol Methods. 2009 Dec;162(1-2):22-9. doi: 10.1016/j.jviromet.2009.07.002. Epub 2009 Jul 21.
The virus envelope (E) protein of Japanese encephalitis virus induces virus-neutralizing antibodies and is therefore a potential vaccine antigen. In a mammalian system, co-expression of another viral structural protein prM is necessary for proper expression and folding of E protein. Transgenic tobacco plants were produced carrying JEV cDNA encoding prM and E proteins under the control of the CaMV 35S promoter. E protein, however, was not detectable in these plants. In vitro translation studies showed that the presence of the prM sequence inhibited transgene expression in the plant system. Accordingly, JEV E protein could be expressed in transgenic tobacco plants only without the prM protein.
日本脑炎病毒的病毒包膜(E)蛋白诱导病毒中和抗体,因此是一种潜在的疫苗抗原。在哺乳动物系统中,另一种病毒结构蛋白 prM 的共表达对于 E 蛋白的正确表达和折叠是必要的。携带 JEV cDNA 编码 prM 和 E 蛋白的转基因烟草植物在 CaMV 35S 启动子的控制下产生。然而,在这些植物中无法检测到 E 蛋白。体外翻译研究表明,prM 序列的存在抑制了植物系统中转基因的表达。因此,只有在没有 prM 蛋白的情况下,JEV E 蛋白才能在转基因烟草植物中表达。